Earlier this week, the European Commission followed the advice of its human medicines advisory committee, the CHMP, and revoked ... remains valid until further notice. In a statement, Advanz ...
SHELTON, CT / ACCESS Newswire / March 11, 2025 / NanoViricides, Inc. (the "Company"), a clinical-stage global leader developing revolutionary broad-spectrum antiviral drugs that the viruses cannot ...
Regulations governing visa policies and other immigration matters fall under a “foreign affairs” exception to the ...
Health and Human Services (HHS) will no longer use notice-and-comment rulemaking procedures for “matters relating to agency management or personnel or to public property, loans, grants, benefits, or ...
On Monday, March 3, 2025, the Massachusetts Supreme Judicial Court (“SJC”) heard argument in Miele v. Foundation Medicine, Inc., regarding whether the Massachusetts Noncompetition Agreement Act, G. L.
2d
Pharmaceutical Technology on MSNOrphelia explores avenues for liquid neuroblastoma med after EU CHMP rejectionEurope’s drug regulatory agency has given Kizfizo a negative opinion for the second time, following one from November 2024.
The CHMP has backed approval of Tecvayli for adults with relapsed and refractory multiple myeloma who have received at least three prior therapies – including an immunomodulatory agent ...
The years-long effort to repeal the certificate of need process for health care facilities and equipment took a blow Feb. 24, ...
The years-long effort to repeal the certificate of need process for health care facilities and equipment took a blow Feb. 24, but not a fatal one, according to Gov. Patrick Morrisey. As Morrisey ...
OPM recommended all agencies redesignate their CHCOs as "general" rather than "career reserved," opening the positions to political appointees.
UN experts have accused Israel of committing sexual violence in Gaza, targeting hospitals and civilians, disproportionately affecting women and children. Israel rejects the UN's findings, labeling ...
Pharmaceutical Technology is the independent source for information, insight, and analysis on bio/pharmaceutical formulation, development, and manufacturing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results